Effects of amlodipine on glomerular filtration, growth, and injury in experimental hypertension

Hypertension

Volumn 27, Issue 2, 1996, Pages 245-250

  Dworkin, Lance D ^a,c   Tolbert, Evelyn ^a   Recht, Phoebe A ^b   Hersch, Jonathan C ^b   Feiner, Helen ^b   Levin, Richard I ^b  

^a BROWN UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

Author keywords

calcium channel blocker; glomerular sclerosis; hemodynamics; hypertrophy; mineralocorticoid; rats, inbred SHR

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST; DEOXYCORTICOSTERONE; DIHYDROPYRIDINE DERIVATIVE; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION; HYPERTENSION; KIDNEY MASS; KIDNEY TUBULE PRESSURE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; ORGAN GROWTH; PRIORITY JOURNAL; PROTEINURIA; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE AGGREGATION; UNINEPHRECTOMY;

EID: 0030022666     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.2.245     Document Type: Article

References (36)

1. Anderson S, Rennke HG, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest. 1986;77:1993-2000.
2. Dworkin LD, Grosser M, Feiner HD, Ullian M, Parker M. Renal vascular effects of antihypertensive therapy in uninephrectomized SHR. Kidney Int. 1989;35:790-798.
3. Dworkin LD, Feiner HD, Parker M, Tolbert E. Effects of nifedipine and enalapril on glomerular structure and function in uninephrectomized SHR. Kidney Int. 1991;39:1112-1117.
4. Zucchelli P, Zuccala A, Borghi M, Fusaroli M, Sasdelli M, Stallone C, Sanna G, Gaggi R. Long term comparison between captopril and nifedipine in the progression of renal insufficiency. Kidney Int. 1992;42:452-458.
5. Parving HH, Anderson AR, Smidt UM, Hammel E, Mathiesen ER, Svenden PA. Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J. 1987;294:1443-1447.
6. Dworkin LD. Effect of nifedipine and enalapril on glomerular injury in rats with desoxycorticosterone-salt hypertension. Am J Physiol. 1990;259:F598-F604.
7. Harris DCH, Hammond WS, Burke TJ, Schrier RW. Verapamil protects against progression of experimental chronic renal failure. Kidney Int. 1987;31:41-46.
8. Brunner FP, Thiel G, Hermle M, Bock HA, Mihatsch MJ. Long-term enalapril and verapamil in rats with reduced renal mass. Kidney Int. 1989;36:969-977.
9. Dworkin LD, Feiner HD. Glomerular injury in uninephrectomized spontaneously hypertensive rats: a consequence of glomerular capillary hypertension. J Clin Invest. 1986;77:797-809.
10. Dworkin LD, Hostetter TH, Rennke HG, Brenner BM. Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension. J Clin Invest. 1984;3:1448-1461.
11. Elias H, Hennig A, Schwartz DE. Stereology: applications to biomedical research. Physiol Rev. 1971;51:158-200.
12. Levin RI, Jaffe EA, Weksler BB, Tack-Goldman K. Nitroglycerin stimulates synthesis of prostacyclin by cultured human endothelial cells. J Clin Invest. 1981;67:762-769.
13. Allison MEM, Lipham EM, Gottschalk CW. Hydrostatic pressure in the rat kidney. Am J Physiol. 1972;223:975-983.
14. Hostetter TH, Rennke HG, Brenner BM. The case for intrarenal hypertension in the initiation and progression of diabetic and other giomerulopathies. Am J Med. 1982;72:375-380.
15. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol. 1981;241:F85-F93.
16. Anderson S. Renal hemodynamic effects of calcium antagonists in rats with reduced renal mass. Hypertension. 1991;17:288-295.
17. Pelayo JC, Harris DCH, Shanley PF, Miller GJ, Schrier RW. Glomerular hemodynamic adaptations in remnant nephrons: effects of verapamil. Am J Physiol. 1988;254:F425-F431.
18. Dworkin LD, Parker M, Tolbert E, Feiner H. Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms. Kidney Int. 1993;43:808-814.
19. Klahr S, Schreiner G, Ichikawa I. The progression of renal disease. N Engl J Med. 1988;318:1657-1666.
20. Yoshida Y, Kawamura T, Ikoma M, Fogo A, Ichikawa I. Effects of antihypertensive drugs on glomerular morphology. Kidney Int. 1989;36:626-635.
21. Yoshida Y, Fogo A, Ichikawa I. Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis. Kidney Int. 1989;35:654-660.
22. Meyer TW, Rennke HG. Progressive glomerular injury following limited infarction in the rat. Am J Physiol. 1988;254:F856-F862.
23. Benstein JA, Feiner HD, Parker M, Dworkin LD. Superiority of salt restriction over diuretics in reducing renal hypertrophy and injury in uninephrectomized SHR. Am J Physiol. 1990;258:F1675-F1681.
24. Lax DS, Benstein JA, Tolbert E, Dworkin LD. Effects of salt restriction on renal growth and glomerular injury in rats with remnant kidneys. Kidney Int. 1992;41:1527-1534.
25. Daniels BS, Hostetter TH. Adverse effects of growth in the glomerular microcirculation. Am J Physiol. 1990;258:F1409-F1416.
26. 3. Kidney Int. 1986;29:1124-1130.
27. Bidani AK, Griffin KA, Picken M, Lansky DM. Continuous telemetric blood pressure monitoring and glomerular injury in the rat remnant kidney model. Am J Physiol. 1993;265:F391-F398.
28. Burges R, Moisey D. Unique pharmacologic properties of amlodipine. Am J Cardiol. 1994;73:2A-9A.
29. Oravcova J, Sojkova D, Fetkovska N, Trnovec T. Factors influencing isradipine and amlodipine binding to human plasma lipoproteins. Blood Press Suppl. 1994;1:61-64.
30. Naylor WG, Gu XH. [3H] amlodipine binding to rat cardiac membranes. J Cardiovasc Pharmacol. 1991;17:587-592.
31. Cheng CP, Noda T, Nordlander M, Ohno M, Little WC. Comparison of effects of dihydropyridine calcium antagonists on left ventricular systolic and diastolic performance. J Pharmacol Exp Ther. 1994;268:1232-1241.
32. Susic D, Mandel AK, Kentera D. Heparin lowers blood pressure in hypertensive rats. Hypertension. 1982;4:681-685.
33. Klahr S, Heifets M, Purderson ML. The influence of anticoagulation on the progression of experimental renal disease. In: Mitch WE, ed. The Progressive Nature of Renal Disease. New York, NY: Churchill Livingstone Inc; 1986:45-64.
34. Purkerson ML, Joist JH, Greenberg JM, Kay D, Hoffsten PE, Klahr S. Inhibition by anticoagulant drugs of the progressive hypertension and uremia associated with renal infarction in rats. Thromb Res. 1982;26:227-240.
35. Purkerson ML, Joist JH, Yates J, Valdes A, Morrison A, Klahr S. Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation. Proc Natl Acad Sci U S A. 1985;82:193-197.
36. Dale J, Landmark KH, Myhre E. The effect of nifedipine, a calcium antagonist, on platelet function. Am Heart J. 1983;105:103-105.